><title>References</title><ref id="b1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rappuoli</surname><given-names>R</given-names></name><name><surname>Aderem</surname><given-names>A</given-names></name></person-group><article-title>A 2020 vision for vaccines against HIV, tuberculosis and malaria</article-title><source>Nature</source><year>2011</year><volume>473</volume><fpage>463</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21614073</pub-id></element-citation></ref><ref id="b2"><label>2</label><element-citation publication-type="book"><collab>WHO</collab><source>Global Tuberculosis Report 2013</source><year>2013</year><publisher-loc>Geneva</publisher-loc><publisher-name>WHO Press</publisher-name></element-citation></ref><ref id="b3"><label>3</label><element-citation publication-type="book"><collab>UNAIDS</collab><source>Global Report UNAIDS report on the global AIDS epidemic 2013</source><year>2013</year><publisher-loc>Geneva</publisher-loc><publisher-name>WHO</publisher-name></element-citation></ref><ref id="b4"><label>4</label><element-citation publication-type="book"><collab>WHO</collab><source>World Malaria Report 2012: WHO Global Malaria Programme</source><year>2012</year><publisher-loc>Geneva</publisher-loc><publisher-name>WHO</publisher-name></element-citation></ref><ref id="b5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SHE</given-names></name></person-group><article-title>Fact and fiction in tuberculosis vaccine research: 10&#x000a0;years later</article-title><source>Lancet Infect Dis</source><year>2011</year><volume>11</volume><fpage>633</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">21798463</pub-id></element-citation></ref><ref id="b6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SHE</given-names></name></person-group><article-title>Tuberculosis vaccines: time to think about the next generation</article-title><source>Semin Immunol</source><year>2013</year><volume>25</volume><fpage>172</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">23706597</pub-id></element-citation></ref><ref id="b7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SHE</given-names></name></person-group><article-title>Future vaccination strategies against tuberculosis: thinking outside the box</article-title><source>Immunity</source><year>2010</year><volume>33</volume><fpage>567</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">21029966</pub-id></element-citation></ref><ref id="b8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gengenbacher</surname><given-names>M</given-names></name><name><surname>Kaufmann</surname><given-names>SHE</given-names></name></person-group><article-title><italic>Mycobacterium tuberculosis</italic>: success through dormancy</article-title><source>FEMS Microbiol Rev</source><year>2012</year><volume>36</volume><fpage>514</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">22320122</pub-id></element-citation></ref><ref id="b9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Zumla</surname><given-names>AI</given-names></name></person-group><article-title>Tuberculosis</article-title><source>Lancet</source><year>2011</year><volume>378</volume><fpage>57</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">21420161</pub-id></element-citation></ref><ref id="b10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>HL</given-names></name><name><surname>Kaufmann</surname><given-names>SHE</given-names></name></person-group><article-title>The many faces of host responses to tuberculosis</article-title><source>Immunology</source><year>2001</year><volume>103</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11380686</pub-id></element-citation></ref><ref id="b11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group><article-title>The immunological life cycle of tuberculosis</article-title><source>Nat Rev Immunol</source><year>2012</year><volume>12</volume><fpage>581</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">22790178</pub-id></element-citation></ref><ref id="b12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Garra</surname><given-names>A</given-names></name><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name></person-group><article-title>The immune response in tuberculosis</article-title><source>Annu Rev Immunol</source><year>2013</year><volume>31</volume><fpage>475</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">23516984</pub-id></element-citation></ref><ref id="b13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houk</surname><given-names>VN</given-names></name></person-group><article-title>Spread of tuberculosis via recirculated air in a naval vessel: the Byrd study</article-title><source>Ann N Y Acad Sci</source><year>1980</year><volume>353</volume><fpage>10</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">6939378</pub-id></element-citation></ref><ref id="b14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kline</surname><given-names>SE</given-names></name><name><surname>Hedemark</surname><given-names>LL</given-names></name><name><surname>Davies</surname><given-names>SF</given-names></name></person-group><article-title>Outbreak of tuberculosis among regular patrons of a neighborhood bar</article-title><source>N Engl J Med</source><year>1995</year><volume>333</volume><fpage>222</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7791838</pub-id></element-citation></ref><ref id="b15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahan</surname><given-names>CS</given-names></name><name><surname>Zalwango</surname><given-names>S</given-names></name><name><surname>Thiel</surname><given-names>BA</given-names></name><etal/></person-group><article-title>Innate and adaptive immune responses during acute <italic>M.&#x000a0;tuberculosis</italic> infection in adult household contacts in Kampala, Uganda</article-title><source>Am J Trop Med Hyg</source><year>2012</year><volume>86</volume><fpage>690</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22492155</pub-id></element-citation></ref><ref id="b16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>KW</given-names></name><name><surname>de Waal</surname><given-names>MR</given-names></name><name><surname>Coffman</surname><given-names>RL</given-names></name><name><surname>O'Garra</surname><given-names>A</given-names></name></person-group><article-title>Interleukin-10 and the interleukin-10 receptor</article-title><source>Annu Rev Immunol</source><year>2001</year><volume>19</volume><fpage>683</fpage><lpage>765</lpage><pub-id pub-id-type="pmid">11244051</pub-id></element-citation></ref><ref id="b17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>A</given-names></name><name><surname>Fraga</surname><given-names>AG</given-names></name><name><surname>Fountain</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with <italic>Mycobacterium tuberculosis</italic></article-title><source>J Exp Med</source><year>2010</year><volume>207</volume><fpage>1609</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">20624887</pub-id></element-citation></ref><ref id="b18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khader</surname><given-names>SA</given-names></name><name><surname>Bell</surname><given-names>GK</given-names></name><name><surname>Pearl</surname><given-names>JE</given-names></name><etal/></person-group><article-title>IL-23 and IL-17 in the establishment of protective pulmonary CD4(+) T cell responses after vaccination and during <italic>Mycobacterium tuberculosis</italic> challenge</article-title><source>Nat Immunol</source><year>2007</year><volume>8</volume><fpage>369</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">17351619</pub-id></element-citation></ref><ref id="b19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korn</surname><given-names>T</given-names></name><name><surname>Bettelli</surname><given-names>E</given-names></name><name><surname>Oukka</surname><given-names>M</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name></person-group><article-title>IL-17 and Th17 Cells</article-title><source>Annu Rev Immunol</source><year>2009</year><volume>27</volume><fpage>485</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">19132915</pub-id></element-citation></ref><ref id="b20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodworth</surname><given-names>JS</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group><article-title>Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity</article-title><source>Crit Rev Immunol</source><year>2006</year><volume>26</volume><fpage>317</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">17073557</pub-id></element-citation></ref><ref id="b21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewinsohn</surname><given-names>DA</given-names></name><name><surname>Gold</surname><given-names>MC</given-names></name><name><surname>Lewinsohn</surname><given-names>DM</given-names></name></person-group><article-title>Views of immunology: effector T cells</article-title><source>Immunol Rev</source><year>2011</year><volume>240</volume><fpage>25</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">21349084</pub-id></element-citation></ref><ref id="b22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Hanson</surname><given-names>DA</given-names></name><name><surname>Teitelbaum</surname><given-names>R</given-names></name><etal/></person-group><article-title>An antimicrobial activity of cytolytic T cells mediated by granulysin</article-title><source>Science</source><year>1998</year><volume>282</volume><fpage>121</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9756476</pub-id></element-citation></ref><ref id="b23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacMicking</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>QW</given-names></name><name><surname>Nathan</surname><given-names>C</given-names></name></person-group><article-title>Nitric oxide and macrophage function</article-title><source>Annu Rev Immunol</source><year>1997</year><volume>15</volume><fpage>323</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">9143691</pub-id></element-citation></ref><ref id="b24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberg</surname><given-names>JB</given-names></name><name><surname>Misukonis</surname><given-names>MA</given-names></name><name><surname>Shami</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages</article-title><source>Blood</source><year>1995</year><volume>86</volume><fpage>1184</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">7542498</pub-id></element-citation></ref><ref id="b25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabri</surname><given-names>M</given-names></name><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Shin</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages</article-title><source>Sci Transl Med</source><year>2011</year><volume>3</volume><fpage>104ra102</fpage></element-citation></ref><ref id="b26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bermudez</surname><given-names>LE</given-names></name><name><surname>Young</surname><given-names>LS</given-names></name></person-group><article-title>Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill <italic>Mycobacterium avium</italic> complex</article-title><source>J Leukoc Biol</source><year>1990</year><volume>48</volume><fpage>67</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">2113563</pub-id></element-citation></ref><ref id="b27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PT</given-names></name><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><etal/></person-group><article-title>Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response</article-title><source>Science</source><year>2006</year><volume>311</volume><fpage>1770</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">16497887</pub-id></element-citation></ref><ref id="b28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>CE</given-names><suffix>III</suffix></name><name><surname>Boshoff</surname><given-names>HI</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name><etal/></person-group><article-title>The spectrum of latent tuberculosis: rethinking the biology and intervention strategies</article-title><source>Nat Rev Microbiol</source><year>2009</year><volume>7</volume><fpage>845</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">19855401</pub-id></element-citation></ref><ref id="b29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>DB</given-names></name><name><surname>Gideon</surname><given-names>HP</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name></person-group><article-title>Eliminating latent tuberculosis</article-title><source>Trends Microbiol</source><year>2009</year><volume>17</volume><fpage>183</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">19375916</pub-id></element-citation></ref><ref id="b30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maglione</surname><given-names>PJ</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name></person-group><article-title>How B cells shape the immune response against <italic>Mycobacterium tuberculosis</italic></article-title><source>Eur J Immunol</source><year>2009</year><volume>39</volume><fpage>676</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">19283721</pub-id></element-citation></ref><ref id="b31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comas</surname><given-names>I</given-names></name><name><surname>Chakravartti</surname><given-names>J</given-names></name><name><surname>Small</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Human T cell epitopes of <italic>Mycobacterium tuberculosis</italic> are evolutionarily hyperconserved</article-title><source>Nat Genet</source><year>2010</year><volume>42</volume><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">20495566</pub-id></element-citation></ref><ref id="b32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aagaard</surname><given-names>CS</given-names></name><name><surname>Hoang</surname><given-names>TT</given-names></name><name><surname>Vingsbo-Lundberg</surname><given-names>C</given-names></name><name><surname>Dietrich</surname><given-names>J</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name></person-group><article-title>Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from <italic>Mycobacterium tuberculosis</italic></article-title><source>J Immunol</source><year>2009</year><volume>183</volume><fpage>2659</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">19620314</pub-id></element-citation></ref><ref id="b33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>MJ</given-names></name><name><surname>Delogu</surname><given-names>G</given-names></name></person-group><article-title>The PE multigene family: a &#x02018;molecular mantra&#x02019; for mycobacteria</article-title><source>Trends Microbiol</source><year>2002</year><volume>10</volume><fpage>246</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11973159</pub-id></element-citation></ref><ref id="b34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talarico</surname><given-names>S</given-names></name><name><surname>Cave</surname><given-names>MD</given-names></name><name><surname>Foxman</surname><given-names>B</given-names></name><etal/></person-group><article-title>Association of <italic>Mycobacterium tuberculosis</italic> PE PGRS33 polymorphism with clinical and epidemiological characteristics</article-title><source>Tuberculosis (Edinb)</source><year>2007</year><volume>87</volume><fpage>338</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">17475562</pub-id></element-citation></ref><ref id="b35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffares</surname><given-names>DC</given-names></name><name><surname>Pain</surname><given-names>A</given-names></name><name><surname>Berry</surname><given-names>A</given-names></name><etal/></person-group><article-title>Genome variation and evolution of the malaria parasite <italic>Plasmodium falciparum</italic></article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>120</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17159978</pub-id></element-citation></ref><ref id="b36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawashima</surname><given-names>Y</given-names></name><name><surname>Pfafferott</surname><given-names>K</given-names></name><name><surname>Frater</surname><given-names>J</given-names></name><etal/></person-group><article-title>Adaptation of HIV-1 to human leukocyte antigen class I</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>641</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">19242411</pub-id></element-citation></ref><ref id="b37"><label>37</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Calmette</surname><given-names>A</given-names></name><name><surname>Gu&#x000e9;rin</surname><given-names>C</given-names></name><name><surname>Boquet</surname><given-names>A</given-names></name><name><surname>N&#x000e9;gre</surname><given-names>L</given-names></name></person-group><source>La vaccination pr&#x000e9;ventive contre la tuberculose par le &#x0201c;BCG&#x0201d;</source><year>1927</year><publisher-loc>Paris</publisher-loc><publisher-name>Masson</publisher-name></element-citation></ref><ref id="b38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hesseling</surname><given-names>AC</given-names></name><name><surname>Marais</surname><given-names>BJ</given-names></name><name><surname>Gie</surname><given-names>RP</given-names></name><etal/></person-group><article-title>The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children</article-title><source>Vaccine</source><year>2007</year><volume>25</volume><fpage>14</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16959383</pub-id></element-citation></ref><ref id="b39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Brewer</surname><given-names>TF</given-names></name><name><surname>Berkey</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature</article-title><source>JAMA</source><year>1994</year><volume>271</volume><fpage>698</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">8309034</pub-id></element-citation></ref><ref id="b40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benn</surname><given-names>CS</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Selin</surname><given-names>LK</given-names></name><name><surname>Aaby</surname><given-names>P</given-names></name></person-group><article-title>A small jab - a big effect: nonspecific immunomodulation by vaccines</article-title><source>Trends Immunol</source><year>2013</year><volume>34</volume><fpage>431</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23680130</pub-id></element-citation></ref><ref id="b41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tameris</surname><given-names>MD</given-names></name><name><surname>Hatherill</surname><given-names>M</given-names></name><name><surname>Landry</surname><given-names>BS</given-names></name><etal/></person-group><article-title>Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial</article-title><source>Lancet</source><year>2013</year><volume>381</volume><fpage>1021</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23391465</pub-id></element-citation></ref><ref id="b42"><label>42</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Frick</surname><given-names>M</given-names></name></person-group><source>The TB Vaccines Pipeline: Where are We Going, Where Have We Been?</source><year>2013</year><publisher-loc>London</publisher-loc><publisher-name>HIV i-Base and Treatment Action Group</publisher-name><fpage>263</fpage><lpage>83</lpage><comment>[2013 Pipeline Report].</comment></element-citation></ref><ref id="b43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smaill</surname><given-names>F</given-names></name><name><surname>Jeyanathan</surname><given-names>M</given-names></name><name><surname>Smieja</surname><given-names>M</given-names></name><etal/></person-group><article-title>A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity</article-title><source>Sci Transl Med</source><year>2013</year><volume>5</volume><fpage>205ra134</fpage></element-citation></ref><ref id="b44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>D</given-names></name><name><surname>Foged</surname><given-names>C</given-names></name><name><surname>Rosenkrands</surname><given-names>I</given-names></name><etal/></person-group><article-title>CAF01 liposomes as a mucosal vaccine adjuvant: <italic>in vitro</italic> and <italic>in vivo</italic> investigations</article-title><source>Int J Pharm</source><year>2010</year><volume>390</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">19879346</pub-id></element-citation></ref><ref id="b45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lingnau</surname><given-names>K</given-names></name><name><surname>Riedl</surname><given-names>K</given-names></name><name><surname>von Gabain</surname><given-names>A</given-names></name></person-group><article-title>IC31 and IC30, novel types of vaccine adjuvant based on peptide delivery systems</article-title><source>Expert Rev Vaccines</source><year>2007</year><volume>6</volume><fpage>741</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17931154</pub-id></element-citation></ref><ref id="b46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Dissel</surname><given-names>JT</given-names></name><name><surname>Arend</surname><given-names>SM</given-names></name><name><surname>Prins</surname><given-names>C</given-names></name><etal/></person-group><article-title>Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived <italic>Mycobacterium tuberculosis</italic> specific T cell responses in naive human volunteers</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>3571</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">20226890</pub-id></element-citation></ref><ref id="b47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aagaard</surname><given-names>C</given-names></name><name><surname>Hoang</surname><given-names>T</given-names></name><name><surname>Dietrich</surname><given-names>J</given-names></name><etal/></person-group><article-title>A multistage tuberculosis vaccine that confers efficient protection pre- and post-exposure</article-title><source>Nat Med</source><year>2011</year><volume>17</volume><fpage>189</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">21258338</pub-id></element-citation></ref><ref id="b48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montoya</surname><given-names>J</given-names></name><name><surname>Solon</surname><given-names>JA</given-names></name><name><surname>Cunanan</surname><given-names>SR</given-names></name><etal/></person-group><article-title>A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-Positive Adults</article-title><source>J Clin Immunol</source><year>2013</year><volume>33</volume><fpage>1360</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">24142232</pub-id></element-citation></ref><ref id="b49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leroux-Roels</surname><given-names>I</given-names></name><name><surname>Leroux-Roels</surname><given-names>G</given-names></name><name><surname>Ofori-Anyinam</surname><given-names>O</given-names></name><etal/></person-group><article-title>Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adults</article-title><source>Clin Vaccine Immunol</source><year>2010</year><volume>17</volume><fpage>1763</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">20861328</pub-id></element-citation></ref><ref id="b50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertholet</surname><given-names>S</given-names></name><name><surname>Ireton</surname><given-names>GC</given-names></name><name><surname>Ordway</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant <italic>Mycobacterium tuberculosis</italic></article-title><source>Sci Transl Med</source><year>2010</year><volume>2</volume><fpage>53ra74</fpage></element-citation></ref><ref id="b51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Reyn</surname><given-names>CF</given-names></name><name><surname>Mtei</surname><given-names>L</given-names></name><name><surname>Arbeit</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine</article-title><source>AIDS</source><year>2010</year><volume>24</volume><fpage>675</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">20118767</pub-id></element-citation></ref><ref id="b52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SHE</given-names></name><name><surname>Gengenbacher</surname><given-names>M</given-names></name></person-group><article-title>Recombinant live vaccine candidates against tuberculosis</article-title><source>Curr Opin Biotechnol</source><year>2012</year><volume>23</volume><fpage>900</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22483201</pub-id></element-citation></ref><ref id="b53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grode</surname><given-names>L</given-names></name><name><surname>Seiler</surname><given-names>P</given-names></name><name><surname>Baumann</surname><given-names>S</given-names></name><etal/></person-group><article-title>Increased vaccine efficacy against tuberculosis of recombinant <italic>Mycobacterium bovis</italic> bacille Calmette-Gu&#x000e9;rin mutants that secrete listeriolysin</article-title><source>J Clin Invest</source><year>2005</year><volume>115</volume><fpage>2472</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16110326</pub-id></element-citation></ref><ref id="b54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grode</surname><given-names>L</given-names></name><name><surname>Ganoza</surname><given-names>CA</given-names></name><name><surname>Brohm</surname><given-names>C</given-names></name><name><surname>Weiner</surname><given-names>J3</given-names></name><name><surname>Eisele</surname><given-names>B</given-names></name><name><surname>Kaufmann</surname><given-names>SHE</given-names></name></person-group><article-title>Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clnical trial</article-title><source>Vaccine</source><year>2013</year><volume>31</volume><fpage>1340</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23290835</pub-id></element-citation></ref><ref id="b55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbues</surname><given-names>A</given-names></name><name><surname>Aguilo</surname><given-names>JI</given-names></name><name><surname>Gonzalo-Asensio</surname><given-names>J</given-names></name><etal/></person-group><article-title>Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated <italic>M.&#x000a0;tuberculosis</italic>-based vaccine to enter clinical trials</article-title><source>Vaccine</source><year>2013</year><volume>31</volume><fpage>4867</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">23965219</pub-id></element-citation></ref><ref id="b56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prabowo</surname><given-names>SA</given-names></name><name><surname>Groschel</surname><given-names>MI</given-names></name><name><surname>Schmidt</surname><given-names>ED</given-names></name><etal/></person-group><article-title>Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines</article-title><source>Med Microbiol Immunol</source><year>2013</year><volume>202</volume><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">23143437</pub-id></element-citation></ref><ref id="b57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardona</surname><given-names>PJ</given-names></name></person-group><article-title>RUTI: a new chance to shorten the treatment of latent tuberculosis infection</article-title><source>Tuberculosis (Edinb)</source><year>2006</year><volume>86</volume><fpage>273</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">16545981</pub-id></element-citation></ref><ref id="b58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bruyn</surname><given-names>G</given-names></name><name><surname>Garner</surname><given-names>P</given-names></name></person-group><article-title><italic>Mycobacterium vaccae</italic> immunotherapy for treating tuberculosis</article-title><source>Cochrane Database Syst Rev</source><year>2010</year><volume>1</volume><fpage>CD001166</fpage><pub-id pub-id-type="pmid">12535403</pub-id></element-citation></ref><ref id="b59"><label>59</label><element-citation publication-type="journal"><collab>Biomarkers Definitions Working Group</collab><article-title>Biomarkers and surrogate endpoints: preferred definitions and conceptual framework</article-title><source>Clin Pharmacol Ther</source><year>2001</year><volume>69</volume><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">11240971</pub-id></element-citation></ref><ref id="b60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zumla</surname><given-names>A</given-names></name><name><surname>Raviglione</surname><given-names>M</given-names></name><name><surname>Hafner</surname><given-names>R</given-names></name><name><surname>von Reyn</surname><given-names>CF</given-names></name></person-group><article-title>Tuberculosis</article-title><source>N Engl J Med</source><year>2013</year><volume>368</volume><fpage>745</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">23425167</pub-id></element-citation></ref><ref id="b61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiner</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>Parida</surname><given-names>SK</given-names></name><name><surname>Maertzdorf</surname><given-names>J</given-names></name><etal/></person-group><article-title>Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e40221</fpage><pub-id pub-id-type="pmid">22844400</pub-id></element-citation></ref><ref id="b62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiner</surname><given-names>J</given-names></name><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Kaufmann</surname><given-names>SHE</given-names></name></person-group><article-title>The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis</article-title><source>Ann N Y Acad Sci</source><year>2013</year><volume>1283</volume><fpage>22</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23181737</pub-id></element-citation></ref><ref id="b63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>JL</given-names></name><name><surname>Nicewander</surname><given-names>WA</given-names></name><name><surname>Toothaker</surname><given-names>L</given-names></name></person-group><article-title>Linearly independent, orthogonal, and uncorrelated variables</article-title><source>Am Stat</source><year>1984</year><volume>38</volume><fpage>133</fpage><lpage>4</lpage></element-citation></ref><ref id="b64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibot</surname><given-names>S</given-names></name><name><surname>Bene</surname><given-names>MC</given-names></name><name><surname>Noel</surname><given-names>R</given-names></name><etal/></person-group><article-title>Combination biomarkers to diagnose sepsis in the critically ill patient</article-title><source>Am J Respir Crit Care Med</source><year>2012</year><volume>186</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">22538802</pub-id></element-citation></ref><ref id="b65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furman</surname><given-names>D</given-names></name><name><surname>Jojic</surname><given-names>V</given-names></name><name><surname>Kidd</surname><given-names>B</given-names></name><etal/></person-group><article-title>Apoptosis and other immune biomarkers predict influenza vaccine responsiveness</article-title><source>Mol Syst Biol</source><year>2013</year><volume>9</volume><fpage>659</fpage><pub-id pub-id-type="pmid">23591775</pub-id></element-citation></ref><ref id="b66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>H</given-names></name><name><surname>Hastie</surname><given-names>T</given-names></name></person-group><article-title>Regularization and variable selection via the elastic net</article-title><source>J R Stat Soc Series B Stat Methodol</source><year>2005</year><volume>67</volume><fpage>301</fpage><lpage>20</lpage></element-citation></ref><ref id="b67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="b68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobsen</surname><given-names>M</given-names></name><name><surname>Repsilber</surname><given-names>D</given-names></name><name><surname>Gutschmidt</surname><given-names>A</given-names></name><etal/></person-group><article-title>Candidate biomarkers for discrimination between infection and disease caused by <italic>Mycobacterium tuberculosis</italic></article-title><source>J Mol Med (Berl)</source><year>2007</year><volume>85</volume><fpage>613</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">17318616</pub-id></element-citation></ref><ref id="b69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Weiner</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>Mollenkopf</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Common patterns and disease-related signatures in tuberculosis and sarcoidosis</article-title><source>Proc Natl Acad Sci USA</source><year>2012</year><volume>109</volume><fpage>7853</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22547807</pub-id></element-citation></ref><ref id="b70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Dass</surname><given-names>RH</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><etal/></person-group><article-title>Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e45839</fpage><pub-id pub-id-type="pmid">23029268</pub-id></element-citation></ref><ref id="b71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koth</surname><given-names>LL</given-names></name><name><surname>Solberg</surname><given-names>OD</given-names></name><name><surname>Peng</surname><given-names>JC</given-names></name><name><surname>Bhakta</surname><given-names>NR</given-names></name><name><surname>Nguyen</surname><given-names>CP</given-names></name><name><surname>Woodruff</surname><given-names>PG</given-names></name></person-group><article-title>Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis</article-title><source>Am J Respir Crit Care Med</source><year>2011</year><volume>184</volume><fpage>1153</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">21852540</pub-id></element-citation></ref><ref id="b72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e70630</fpage><pub-id pub-id-type="pmid">23940611</pub-id></element-citation></ref><ref id="b73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaforou</surname><given-names>M</given-names></name><name><surname>Wright</surname><given-names>VJ</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group><article-title>Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study</article-title><source>PLoS Med</source><year>2013</year><volume>10</volume><fpage>e1001538</fpage><pub-id pub-id-type="pmid">24167453</pub-id></element-citation></ref><ref id="b74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walzl</surname><given-names>G</given-names></name><name><surname>Ronacher</surname><given-names>K</given-names></name><name><surname>Hanekom</surname><given-names>W</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Zumla</surname><given-names>A</given-names></name></person-group><article-title>Immunological biomarkers of tuberculosis</article-title><source>Nat Rev Immunol</source><year>2011</year><volume>11</volume><fpage>343</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">21475309</pub-id></element-citation></ref><ref id="b75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agranoff</surname><given-names>D</given-names></name><name><surname>Fernandez-Reyes</surname><given-names>D</given-names></name><name><surname>Papadopoulos</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum</article-title><source>Lancet</source><year>2006</year><volume>368</volume><fpage>1012</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">16980117</pub-id></element-citation></ref><ref id="b76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Weiner</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>Kaufmann</surname><given-names>SHE</given-names></name></person-group><article-title>Enabling biomarkers for tuberculosis control</article-title><source>Int J Tuberc Lung Dis</source><year>2012</year><volume>16</volume><fpage>1140</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22871324</pub-id></element-citation></ref><ref id="b77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herra</surname><given-names>CM</given-names></name><name><surname>Keane</surname><given-names>CT</given-names></name><name><surname>Whelan</surname><given-names>A</given-names></name></person-group><article-title>Increased expression of Fc gamma receptors on neutrophils and monocytes may reflect ongoing bacterial infection</article-title><source>J Med Microbiol</source><year>1996</year><volume>44</volume><fpage>135</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">8642575</pub-id></element-citation></ref><ref id="b78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Groote</surname><given-names>MA</given-names></name><name><surname>Nahid</surname><given-names>P</given-names></name><name><surname>Jarlsberg</surname><given-names>L</given-names></name><etal/></person-group><article-title>Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e61002</fpage><pub-id pub-id-type="pmid">23637781</pub-id></element-citation></ref><ref id="b79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prior</surname><given-names>C</given-names></name><name><surname>Guillen-Grima</surname><given-names>F</given-names></name><name><surname>Robles</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer</article-title><source>World J Urol</source><year>2010</year><volume>28</volume><fpage>681</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">20632177</pub-id></element-citation></ref><ref id="b80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e46191</fpage><pub-id pub-id-type="pmid">23056259</pub-id></element-citation></ref><ref id="b81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>JJ</given-names></name><name><surname>Lieu</surname><given-names>L</given-names></name><name><surname>Rocke</surname><given-names>D</given-names></name></person-group><article-title>Dimension reduction for classification with gene expression microarray data</article-title><source>Stat Appl Genet Mol Biol</source><year>2006</year><volume>5</volume><fpage>Article6</fpage><pub-id pub-id-type="pmid">16646870</pub-id></element-citation></ref><ref id="b82"><label>82</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hahne</surname><given-names>F</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Gentleman</surname><given-names>R</given-names></name><name><surname>Falcon</surname><given-names>S</given-names></name></person-group><source>Bioconductor Case Studies</source><year>2008</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id="b83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousu</surname><given-names>J</given-names></name><name><surname>Agranoff</surname><given-names>DD</given-names></name><name><surname>Sodeinde</surname><given-names>O</given-names></name><name><surname>Shawe-Taylor</surname><given-names>J</given-names></name><name><surname>Fernandez-Reyes</surname><given-names>D</given-names></name></person-group><article-title>Biomarker discovery by sparse canonical correlation analysis of complex clinical phenotypes of tuberculosis and malaria</article-title><source>PLoS Comput Biol</source><year>2013</year><volume>9</volume><fpage>e1003018</fpage><pub-id pub-id-type="pmid">23637585</pub-id></element-citation></ref><ref id="b84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Ota</surname><given-names>M</given-names></name><name><surname>Repsilber</surname><given-names>D</given-names></name><etal/></person-group><article-title>Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e26938</fpage><pub-id pub-id-type="pmid">22046420</pub-id></element-citation></ref><ref id="b85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Carey</surname><given-names>VJ</given-names></name><name><surname>Chen</surname><given-names>XW</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Draghici</surname><given-names>S</given-names></name></person-group><article-title>Machine learning and its applications to biology</article-title><source>PLoS Comput Biol</source><year>2007</year><volume>3</volume><fpage>e116</fpage><pub-id pub-id-type="pmid">17604446</pub-id></element-citation></ref><ref id="b86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strube</surname><given-names>MJ</given-names></name></person-group><article-title>SNOOP:a program for demonstrating the consequences of premature and repeated null hypothesis testing</article-title><source>Behav Res Methods</source><year>2006</year><volume>38</volume><fpage>24</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16817510</pub-id></element-citation></ref><ref id="b87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>ST</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><etal/></person-group><article-title>Deciphering the biology of <italic>Mycobacterium tuberculosis</italic> from the complete genome sequence</article-title><source>Nature</source><year>1998</year><volume>393</volume><fpage>537</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">9634230</pub-id></element-citation></ref></